Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec;273(8):1629-1631.
doi: 10.1007/s00406-023-01712-9.

Shared Decision Making Assistant (SDMA) and other digital tools for choosing antipsychotics in schizophrenia treatment

Stefan Leucht  1   2 , Spyridon Siafis  3   4 , Alessandro Rodolico  3 , Natalie L Peter  3 , Katharina Müller  3   5 , Jakob Waibel  3 , Wolfgang Strube  6 , Alkomiet Hasan  4   6 , Ingrid Bauer  6 , Peter Brieger  5 , John M Davis  7 , Johannes Hamann  3   8
Affiliations
Editorial

Shared Decision Making Assistant (SDMA) and other digital tools for choosing antipsychotics in schizophrenia treatment

Stefan Leucht et al. Eur Arch Psychiatry Clin Neurosci. 2023 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

In the last three years Stefan Leucht has received honoraria as advisor and/or for lectures and/or for educational material from Alkermes, Angelini, Apsen, Eisai, Gedeon Richter, Janssen, Karuna, Kynexis, Lundbeck, Medichem, Medscape, Merck Sharp and Dohme, Mitshubishi, Neurotorium, NovoNordisk, Otsuka, Recordati, Roche, Rovi, Sanofi Aventis, and TEVA. Alkomiet Hasan has been on the advisory boards of Janssen, Lundbeck, Recordati, Rovi and Otsuka and received speaker fees from those companies and from AbbVie. W. Strube has received a speaker’s honorarium from Mag&More GmbH and neurocare and was a member of the advisory board of Recordati. Spyridon Siafis, Alessandro Rodolico, Natalie L. Peter, Ingrid Bauer, Peter Brieger, none to declare. Johannes Hamann received lecture honoraria from Janssen, Otsuka, Lundbeck and Rovi.

Figures

Fig. 1
Fig. 1
The interfaces of Shared Decision Making Assistant
See this image and copyright information in PMC

References

    1. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104:510–520. doi: 10.1258/jrsm.2011.110180. - DOI - PMC - PubMed
    1. Davidoff F, Haynes B, Sackett D, Smith R. Evidence based medicine. Br Med J. 1995;310:1085–1086. doi: 10.1136/bmj.310.6987.1085. - DOI - PMC - PubMed
    1. Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Backers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939–951. doi: 10.1016/S0140-6736(19)31135-3. - DOI - PMC - PubMed
    1. Pillinger T, Howes OD, Correll CU, Leucht S, Huhn M, Schneider-Thoma J, Gaughran F, Jauhar S, McGuire PK, Taylor DM, Young AH, McCutcheon RA. Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development. Lancet Psychiatry. 2023;10:860–876. doi: 10.1016/S2215-0366(23)00262-6. - DOI - PubMed
    1. van Dijk F, de Wit I, Blankers M, Sommer I, de Haan L. The Personal antipsychotic choice index. Pharmacopsychiatry. 2018;51:89–99. doi: 10.1055/s-0043-116854. - DOI - PubMed

Publication types

Substances

LinkOut - more resources